Presenting Companies Speakers and Company Descriptions

Anterix is focused on delivering transformative private broadband that enables the modernization of critical infrastructure for multiple sectors of our economy including energy, transportation and logistics. We are the largest holder of licensed spectrum in the 900 MHz band (896-901/935-940 MHz) throughout the contiguous United States, plus Hawaii, Alaska, and Puerto Rico. Our spectrum uniquely positions us to enable private LTE solutions that support secure, resilient and customer-controlled operations.

Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead drug candidate, oxylanthanum carbonate (OLC), is a novel investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. UNI-494 is a patent-protected new chemical entity in Phase 1 clinical trial for the treatment of acute kidney injury.